We continue to recognize Texas Retina team members who have served our practice for 20 years or more. Today, we honor Rita Vegas, who joined Texas Retina in 2002 and currently serves as Supervisor of Eligibility & Benefits in our Dallas Main office. Throughout her career at Texas Retina, Rita has served in several roles, including as a receptionist and surgical coordinator before joining and then leading the eligibility and benefits team. When asked what keeps her passionate about her work after more than two decades, Rita commented: “I love being able to assist the doctors and patien ..read more

Ocular (uveal) melanoma is a rare but dangerous disease, and only a small number of doctors in the United States treat it. At Texas Retina, we have been caring for ocular melanoma patients for over 40 years and are fortunate to currently have two physicians who sub-specialize in treating this rare eye cancer: Dr. Timothy Fuller and Dr. Rajiv Anand.  Click here to access a brief video where Dr. Timothy Fuller explains ocular melanoma, including current treatment options and promising new research.  You can also learn more about ocular melanoma here.  The post May is Ocular M ..read more

At this year’s ARVO 2024, the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO), Texas Retina’s Dr. Abbey presented 36-month data from the GALE study of pegcetacoplan (brand name Syfovre), the first-ever treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). GALE is a 3-year extension study involving patients who were in the Phase III clinical trials — DERBY and OAKS — which led to the FDA approval of pegcetacoplan for the treatment of geographic atrophy. All patients were treated either monthly or every other month. Dr ..read more

Under the leadership of principal investigator Timothy Fuller, MD, Texas Retina is now participating in the Phase III AU-011 clinical trial (CoMpass) for treatment of small choroidal (ocular) melanoma. Together with Aura Biosciences, we are investigating the safety and efficacy of belzupacap sarotalocan (AU-011), a light-activated viral nanoparticle, in the treatment of this rare and often deadly cancer. Texas Retina previously participated in the Phase II trial where Dr. Timothy Fuller was the first in the nation to treat a patient with AU-011 delivered via suprachoroidal injection. Following ..read more

The National Eye Institute has designated May as Healthy Vision Month. It is the perfect time to learn how to protect your eyes and vision, and to encourage your family members to do the same. Here are a few helpful tips: Wear sunglasses (even on cloudy days!). They help protect your eyes from the sun’s ultraviolet (UV) rays. Look for shades that block out at least 99% of both UVA and UVB radiation. Eat eye-healthy foods. You may know carrots are good for your eyes, but so is a diet rich in all kinds of vegetables and fruits — especially dark, leafy greens like spinach and kale. Fish ric ..read more

As we recognize team members who have been a part of the Texas Retina family for 20+ years, today we are celebrating Angela Smith. She joined our practice in 2002 and currently works as a reconciliation specialist in our Dallas Main office. Throughout Angela’s career at Texas Retina, she has filled several roles, including medical records, front desk, transcription and accounts receivable before moving into her current position. When asked what she loves most about her work at Texas Retina, Angela shared: “I enjoy helping our patients in any capacity needed. I also like the camaraderie ..read more

As the leading cause of vision loss in older adults, age-related macular degeneration (AMD) is the most common reason patients are referred to Texas Retina. It happens when the central part of the retina, called the macula, is damaged. There are two forms of the disease. Dry AMD is the most common and is characterized by accumulation of yellow deposits called drusen, thinning of the macula, and gradual deterioration of central vision. Everyone with AMD starts out with the dry form, and about 10-15% will go on to develop wet AMD, a more serious form of the disease where abnormal blood ves ..read more

We continue to recognize Texas Retina team members who have served our practice for 20 years or more. Today, we are honoring Jennifer Hager Ward, who joined Texas Retina in 1997, and currently serves as a charge entry specialist in our Plano office. Jennifer began her career at Texas Retina as a receptionist and then moved to the billing department. When asked what she loves most about Texas Retina, she shared the following: “I enjoy what I do and have made some good friends. What I love most is the work environment and the people I work with. We have a great team that gets along and work ..read more

Our Waco/Woodway office phones are back up! We apologize again for the inconvenience and appreciate your patience as we worked to resolve the issue. The post Waco Office Phones Working Again first appeared on Texas Retina Associates ..read more

We are continuing to celebrate our team members who have been a part of the Texas Retina family for 20 years or more. Today we recognize Kimberly Jones who joined our team in 1998 and works in our Plano office. She began with us as an accounts receivable clerk and now works as a charge entry specialist. When asked what keeps her passionate about her work at Texas Retina, Kimberly shared: “Texas Retina cares about my well-being. I have a great boss and a great team that I work with. I love that I have a sense of purpose, an engaging task and a supportive environment.” Thank you, Kimberly ..read more